🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multidimensional Characterization of Dyspnea in Children

Recruitingn/aAges 6 Years - 17 YearsAllAssistance Publique - Hôpitaux de Paris
NCT05500833 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

There is no specific tool existing to describe dyspnea in children in a multidimensional way. It has been shown in adult studies that multidimensional dyspnea evaluation scales are well correlated to quality of life and respiratory function impairments. The investigators hypothesis is that using multidimensional dyspnea evaluation scales could allow for a more systematic and precise evaluation of this symptom in children, thus improving management and follow-up of patients presenting with acute (asthma attack, infectious diseases) and chronic (cystic fibrosis, primary ciliary diskynesia, neuromuscular diseases) respiratory insufficiency.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children aged between 6-17 years old at inclusion * Experiencing respiratory complaints at inclusion * Social security number * Children whom parents or legal representatives are present or reachable via phone call at inclusion * Non-opposition of parents or legal representatives to participate in the study * Children who are followed at or hospitalized in Trousseau hospital's pediatric pulmonology department for: asthma attack, acute respiratory insufficiency, acute exacerbation of a chronic respiratory disease, chronic respiratory insufficiency. * For the study of acute dyspnea: patients hospitalized for acute respiratory disease since less than 72h. * For the study of chronic dyspnea: children presenting with chronic respiratory disease. Exclusion Criteria: * Cognitive disorders making it impossible to understand self-assessment scales * Refusal of the child to participate in the research For the assessment of chronic dyspnea: * Children followed for a chronic respiratory pathology having presented an episode of acute respiratory decompensation in the 6 weeks preceding inclusion.
💊

What it tests

  • Multidimentional observation scale (MDP)
📍

Where

1 site
Service de pneumologie pédiatrique, Hôpital Armand Trousseau
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy